Fill/finish is one of the most critical stages in the manufacturing journey, where decisions around process design, technology selection, and operational readiness can have a lasting impact on product quality and supply performance. As biologics and other complex therapies advance toward commercialization, sponsors must balance evolving technical requirements with the need for reliability, flexibility, and speed.
In this edition of the Outsourced Pharma Capabilities Update (OPCU), industry experts share perspectives on the fill/finish considerations shaping successful development and manufacturing strategies. From aseptic processing and technology transfer to capacity planning and supply chain readiness, these presentations highlight practical approaches for overcoming common challenges while positioning programs for long-term success. Watch the presentations below to learn how leading CDMOs are helping sponsors strengthen manufacturing readiness from clinical development through commercial launch.
Recent Sessions Available On-Demand
Nanoparticles & Solid Dose Formulation – September 2026
Cell Line Development – August 2026
Upcoming OPCU Topics & Times
Advancing Drug Substance Manufacturing | 10/28/2026, AM Session
Small Molecule Drug Product Innovation | 10/28/2026, AM Session
Enabling Success In Cell & Gene Therapy | 10/29/2026, AM Session
Advancing Analytical Capabilities | 10/29/2026, PM Session
Solving Solubility & Bioavailability Challenges | 11/10/2026, AM Session
Enabling ADC Success | 12/1/2026, AM Session
Mastering Aseptic Fill/Finish | 12/1/2026, PM Session
Access more on-demand OPCU recordings and upcoming sessions here.
